How to Reduce Bloating: Common Causes and Evidence-Based Approaches

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Quick answer:

Bloating most commonly results from gut bacteria fermenting undigested carbohydrates — including FODMAPs — that produce carbon dioxide, hydrogen, and methane gas. Approximately 65–70% of adults worldwide have reduced lactase activity, one common contributor. Persistent bloating may also signal celiac disease, SIBO, IBS, gastroparesis, or hypothyroidism, each requiring a distinct diagnostic and management approach.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Quick answer: Bloating is most commonly caused by gas accumulation from gut bacteria fermenting undigested carbohydrates, but persistent or severe bloating can also reflect food intolerances, celiac disease, small intestinal bacterial overgrowth (SIBO), functional gut disorders, or less commonly, inflammatory or structural conditions. Identifying the cause matters because the appropriate approach differs significantly by mechanism.

Why bloating is worth taking seriously

Bloating — the sensation of abdominal fullness, pressure, or visible distension — is among the most common gastrointestinal complaints reported to clinicians. For many people it is episodic and clearly linked to specific foods. For others, it is persistent, unpredictable, and disproportionately affects quality of life. The distinction matters clinically: episodic bloating tied to identifiable dietary triggers is generally a gut-physiology question, while persistent bloating with no clear pattern may warrant broader investigation.

The causes of bloating range from normal physiological responses to dietary components, to conditions such as celiac disease and small intestinal bacterial overgrowth (SIBO) that require specific identification, to functional disorders such as irritable bowel syndrome (IBS) where the bloating mechanism is multifactorial. Understanding which mechanism is at play determines what approaches are likely to be useful.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Common causes of bloating and what drives each

1. Fermentable carbohydrates and the microbiome

The most common physiological cause of bloating is the fermentation of undigested carbohydrates by colonic bacteria. Humans lack the enzymes to break down certain carbohydrate structures — including some dietary fibers, resistant starches, and a group of short-chain carbohydrates collectively called FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols). When these reach the colon intact, gut bacteria ferment them, producing carbon dioxide, hydrogen, and methane gas as byproducts. The gas itself is not the only factor: how the gut handles gas volume, and the sensitivity of gut mechanoreceptors, determines whether the same gas load produces symptoms or not.

A diet systematically higher in high-FODMAP foods — including wheat, onions, garlic, legumes, lactose-containing dairy, apples, and certain sweeteners — tends to produce more fermentation gas, and individuals with a sensitive gut are more likely to perceive this as bloating or discomfort. A low-FODMAP elimination approach is one of the more evidence-supported dietary strategies for IBS-associated bloating in clinical trial settings, though it is restrictive and typically implemented under the guidance of a registered dietitian.

2. Celiac disease

Celiac disease is an autoimmune condition in which ingestion of gluten triggers an immune-mediated response that damages the lining of the small intestine. Bloating, abdominal pain, and altered bowel habits are among the most frequently reported gastrointestinal symptoms. However, celiac disease can also present with non-gastrointestinal symptoms — iron deficiency anemia, fatigue, bone density loss, or dermatitis herpetiformis — or with minimal symptoms despite active intestinal inflammation.

Celiac disease is significantly underdiagnosed. Population studies estimate that the majority of affected individuals remain undiagnosed. Serological testing — specifically tissue transglutaminase IgA (tTG-IgA) antibody — is the standard first-line screen. Importantly, a total IgA level should be measured simultaneously to ensure the tTG-IgA result is valid, as IgA deficiency can produce a falsely negative result. Testing requires that gluten be part of the diet at the time of testing; prior gluten elimination will suppress the antibody response and may yield a false negative.

3. Lactose intolerance

Lactase is the enzyme that breaks down lactose, the primary sugar in dairy products. Lactase production declines after early childhood in most of the global population — a normal physiological shift called lactase non-persistence, affecting approximately 65-70% of adults worldwide. In individuals with low lactase activity, undigested lactose passes into the colon where it is fermented by bacteria, producing gas, bloating, and often urgency or diarrhea within 30 to 120 minutes of consuming dairy.

Lactose intolerance can be assessed through a hydrogen breath test (the clinical standard), a lactose tolerance test (measuring blood glucose rise after lactose ingestion), or through a supervised elimination and reintroduction of dairy. Genetic testing for the lactase persistence gene variant (LCT rs4988235) can also establish biological predisposition, though it does not account for residual lactase activity or individual threshold variation.

4. Small intestinal bacterial overgrowth (SIBO)

SIBO refers to an excess of bacteria in the small intestine — a segment of the gut that normally has far fewer microorganisms than the colon. When this population grows abnormally, bacteria begin fermenting carbohydrates before they can be properly absorbed, generating gas within the small bowel. Because small bowel distension is particularly sensitive, SIBO-related bloating can be severe and is often described as developing rapidly after meals.

SIBO is diagnosed through hydrogen and/or methane breath testing after a glucose or lactulose challenge dose. Methane-producing organisms (now reclassified as archaea) are associated specifically with constipation-predominant presentations, while hydrogen producers are more associated with diarrhea. SIBO commonly develops in the setting of impaired gut motility, reduced gastric acid production, anatomical changes from prior abdominal surgery, or underlying conditions such as hypothyroidism or diabetes.

5. Irritable bowel syndrome (IBS)

IBS is a functional gut disorder characterized by altered bowel habits, abdominal pain, and bloating without identifiable structural or inflammatory disease. Bloating in IBS is thought to involve a combination of increased gas production, impaired gas transit, heightened visceral sensitivity (where normal amounts of gas produce disproportionate discomfort), and altered gut-brain signaling. There is no blood test that confirms IBS — it is diagnosed by clinical criteria (Rome IV) after excluding other conditions. However, testing inflammatory markers and celiac serology is part of the standard exclusion workup.

6. Gastroparesis and impaired gut motility

When the stomach empties slowly (gastroparesis), food remains in the upper gastrointestinal tract longer than normal, producing early satiety, upper abdominal bloating, nausea, and postprandial discomfort. Gastroparesis is more common in individuals with long-standing diabetes (due to autonomic nerve damage), though it also occurs in other contexts. Relevant metabolic markers include HbA1c and fasting glucose when evaluating for diabetes-related autonomic dysfunction.

7. Thyroid dysfunction

Hypothyroidism slows gastrointestinal motility throughout the gut, which can contribute to constipation, bloating, and abdominal distension. While gastrointestinal symptoms from hypothyroidism are rarely the sole presentation, they are common enough that TSH is a reasonable inclusion in a workup for persistent unexplained bloating, particularly when accompanied by other hypothyroid symptoms such as fatigue, weight gain, or cold sensitivity.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Dietary approaches with evidence behind them

Low-FODMAP diet

The low-FODMAP diet reduces fermentable carbohydrates that fuel bacterial gas production. Multiple randomized controlled trials demonstrate symptom improvement in IBS patients following this dietary approach. It is not appropriate as a long-term eating pattern due to its restriction of prebiotic fibers that support gut microbiome diversity; it is typically used as a structured 6 to 8 week elimination followed by systematic reintroduction of food groups to identify individual triggers.

Peppermint oil

Enteric-coated peppermint oil has the best evidence base among natural supplements for IBS-related bloating and abdominal pain. A meta-analysis of multiple randomized trials found peppermint oil significantly superior to placebo for IBS symptom relief. The mechanism involves L-menthol's smooth muscle relaxant properties, which reduce intestinal spasm and may facilitate gas transit. Enteric coating is important to prevent early release in the stomach, which can cause heartburn.

Probiotics

The evidence for probiotics in bloating management is mixed and strain-specific. Certain strains — particularly Bifidobacterium infantis, Lactobacillus acidophilus, and multi-strain formulations — have shown benefit in randomized trials for IBS symptom reduction, including bloating. The benefit is not consistent across all products, and the optimal strain selection depends on the underlying gut issue. A Superpower Gut Microbiome Analysis can provide a detailed picture of your microbiome composition as a baseline for targeted intervention.

Biomarkers relevant to persistent bloating

  • tTG-IgA antibody + total IgA — Celiac disease screening. Included in Superpower's Autoimmunity Panel
  • TSH — thyroid function; hypothyroidism slows gut motility
  • Ferritin + CBC — iron deficiency anemia; associated with celiac disease
  • hs-CRP — systemic inflammation; may suggest inflammatory bowel disease
  • Fasting glucose + HbA1c — diabetes; relevant to gastroparesis and autonomic gut dysfunction
  • Vitamin B12 — deficiency associated with celiac and malabsorption syndromes

Superpower's Baseline Blood Panel covers thyroid function, glucose metabolism, ferritin, CBC, and inflammatory markers in a single draw. Combined with the Autoimmunity Panel (which includes celiac serology), it provides a comprehensive starting point for evaluating persistent bloating.

When is bloating worth investigating clinically?

Bloating that is clearly tied to specific foods and resolves promptly is generally a dietary pattern question. Bloating that is persistent across food patterns, progressively worsening, accompanied by unintended weight loss, blood in stool, severe pain, or nighttime symptoms warrants prompt clinical evaluation. These features may suggest conditions that require specific diagnosis and are beyond the scope of dietary modification alone.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health routine. Superpower offers blood panels that include the biomarkers discussed in this article. Links to individual tests are provided for informational context.

Frequently Asked Questions

References

  1. Staudacher HM, Whelan K (2017). The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. *Gut*, *66*(8), 1517-1527. https://doi.org/10.1136/gutjnl-2017-313750
  2. Kvamme JM, Sørbye S, Florholmen J, Halstensen TS (2022). Population-based screening for celiac disease reveals that the majority of patients are undiagnosed and improve on a gluten-free diet. *Scientific reports*, *12*(1), 12647. https://doi.org/10.1038/s41598-022-16705-2
  3. Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023). American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. *The American journal of gastroenterology*, *118*(1), 59-76. https://doi.org/10.14309/ajg.0000000000002075
  4. Bayless TM, Brown E, Paige DM (2017). Lactase Non-persistence and Lactose Intolerance. *Current gastroenterology reports*, *19*(5), 23. https://doi.org/10.1007/s11894-017-0558-9
  5. Lacy BE, Patel NK (2017). Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. *Journal of clinical medicine*, *6*(11). https://doi.org/10.3390/jcm6110099
  6. Camilleri M, Kuo B, Nguyen L, Vaughn VM, Petrey J, Greer K, Yadlapati R, Abell TL (2022). ACG Clinical Guideline: Gastroparesis. *The American journal of gastroenterology*, *117*(8), 1197-1220. https://doi.org/10.14309/ajg.0000000000001874
  7. Shafer RB, Prentiss RA, Bond JH (1984). Gastrointestinal transit in thyroid disease. *Gastroenterology*, *86*(5 Pt 1), 852-5. https://pubmed.ncbi.nlm.nih.gov/6706068/
  8. Black CJ, Staudacher HM, Ford AC (2022). Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. *Gut*, *71*(6), 1117-1126. https://doi.org/10.1136/gutjnl-2021-325214
  9. Alammar N, Wang L, Saberi B, Nanavati J, Holtmann G, Shinohara RT, Mullin GE (2019). The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. *BMC complementary and alternative medicine*, *19*(1), 21. https://doi.org/10.1186/s12906-018-2409-0
  10. Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P (2018). Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. *Alimentary pharmacology & therapeutics*, *48*(10), 1044-1060. https://doi.org/10.1111/apt.15001

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey